Dermapharm Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	225.93	203.41	121.31	158.72	151.02	161.41
Short-Term Investments	-	1.06	0.59	0.82	1.48	1.76
Cash & Short-Term Investments	225.93	204.46	121.9	159.54	152.5	163.18
Cash Growth	96.16%	67.74%	-23.60%	4.62%	-6.54%	32.85%
Accounts Receivable	135.82	110.66	102.18	95.41	96.72	72.52
Other Receivables	1.84	10.78	11.25	40.39	8.41	14.29
Receivables	137.67	121.44	113.43	135.8	105.13	86.81
Inventory	359.66	328.71	343.38	320.76	255.72	243.6
Prepaid Expenses	-	41.91	7.6	7.94	7	13.19
Other Current Assets	56.79	6.4	7.19	6.45	13.6	12.45
Total Current Assets	780.05	702.93	593.5	630.5	533.95	519.22
Property, Plant & Equipment	332.79	318.54	315.03	330.77	225.67	222.29
Long-Term Investments	32.95	33.67	21.87	25.06	36.57	105.62
Goodwill	587.1	587.06	576.38	578.52	271.32	264.73
Other Intangible Assets	473.74	379.09	406.14	441.61	212.12	217.13
Long-Term Deferred Charges	-	101.35	106.18	103.25	92.92	77.72
Other Long-Term Assets	66.03	0.92	0.94	0.97	0.28	0.27
Total Assets	2,273	2,187	2,080	2,161	1,413	1,407
Accounts Payable	114.21	96.26	94.79	86.64	56.1	52.1
Accrued Expenses	-	65.38	67.69	94.35	54.51	45.17
Short-Term Debt	-	0.02	0.04	0.01	0	-
Current Portion of Long-Term Debt	123.18	128.14	86.04	111.43	1.87	2.38
Current Portion of Leases	-	6.86	5.12	5	3.02	3.2
Current Income Taxes Payable	32.37	28.98	58.83	81.82	96.35	48.8
Current Unearned Revenue	-	1.71	1.5	1.43	0.56	0.62
Other Current Liabilities	120.48	15.58	12.91	13.82	5.38	3.35
Total Current Liabilities	390.24	342.93	326.92	394.49	217.79	155.61
Long-Term Debt	916.28	904.09	886.71	963.89	501.84	565.71
Long-Term Leases	-	18.82	12.35	13.25	9.72	9.01
Long-Term Unearned Revenue	-	11.06	11.34	11.69	9.2	9.46
Pension & Post-Retirement Benefits	111.14	111.08	119.63	117.22	89.28	128.88
Long-Term Deferred Tax Liabilities	105.67	105.07	111.7	112.39	50.52	36.06
Other Long-Term Liabilities	14.16	3	3.08	2.71	1.99	2.41
Total Liabilities	1,537	1,496	1,472	1,616	880.34	907.14
Common Stock	53.84	53.84	53.84	53.84	53.84	53.84
Retained Earnings	561.11	515.91	433.19	367.22	355.36	337.95
Comprehensive Income & Other	123.91	124.62	117.39	118.14	122.4	105.52
Total Common Equity	738.86	694.38	604.42	539.21	531.59	497.32
Minority Interest	-3.69	-3.61	3.87	5.84	0.9	2.52
Shareholders' Equity	735.17	690.77	608.3	545.05	532.49	499.83
Total Liabilities & Equity	2,273	2,187	2,080	2,161	1,413	1,407
Total Debt	1,039	1,058	990.26	1,094	516.45	580.3
Net Cash (Debt)	-813.54	-853.46	-868.36	-934.03	-363.95	-417.13
Net Cash Per Share	-15.12	-15.85	-16.13	-17.35	-6.76	-7.75
Filing Date Shares Outstanding	53.81	53.84	53.84	53.84	53.84	53.84
Total Common Shares Outstanding	53.81	53.84	53.84	53.84	53.84	53.84
Working Capital	389.81	360	266.58	236.01	316.16	363.61
Book Value Per Share	13.73	12.90	11.23	10.01	9.87	9.24
Tangible Book Value	-321.99	-271.77	-378.1	-480.92	48.15	15.46
Tangible Book Value Per Share	-5.98	-5.05	-7.02	-8.93	0.89	0.29
Land	-	258.71	247.87	252.54	171.75	163.41
Machinery	-	279.01	252.92	234.8	178.45	163.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.